Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions

Area of Science:

• Genetics
• Cancer Biology
• Epigenetics

Background:

• Recurrent genomic loss is frequent in cancers, but its role in tumor development is often unclear.
• Chromosome 20 deletions are observed in chronic myeloid malignancies, suggesting a link to these cancers.

Purpose of the Study:

• To investigate the role of primate-restricted imprinted genes in chromosome 20 deletions associated with chronic myeloid malignancies.
• To elucidate the pathogenetic mechanism by which loss of specific genes contributes to cancer development.

Main Methods:

• Identification of primate-restricted imprinted genes in the commonly deleted 20q region.
• Analysis of gene expression changes following heterozygous 20q deletions.
• Investigation of the functional collaboration between L3MBTL1 and SGK2 in regulating gene transcription and chromatin structure.

Main Results:

• A heterozygous 20q deletion consistently caused complete loss of expression for imprinted genes L3MBTL1 and SGK2.
• Loss of L3MBTL1 and SGK2 dysregulated erythropoiesis and megakaryopoiesis, affecting key cell lineages in myeloid malignancies.
• L3MBTL1 and SGK2 were found to cooperate in MYC transcriptional regulation by modulating chromatin structure, with L3MBTL1 affecting nucleosomal compaction and SGK2 inactivating BRG1.

Conclusions:

• Acquired genomic deletions can impact cancer pathogenesis through the loss of imprinted genes.
• The identified L3MBTL1-SGK2-BRG1 pathway offers a new mechanism for how genomic deletions contribute to malignancy.
• Understanding these complex molecular events is crucial for deciphering the consequences of chromosome deletions in cancer.